---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036055"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2024-09-12T23:59:59+00:00"
generated_at: "2026-05-31T05:14:31.186764+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes $8.5M public offering of 12.3M shares at $0.69 each

## Summary
- Gross proceeds of $8,504,250 from sale of 12,325,000 common shares at $0.69/share.
- Placement agent ThinkEquity received 7.5% cash fee and 5-year warrants for 616,250 shares at $0.8625.
- Net proceeds to be used for working capital, general corporate purposes, and advancing business objectives.
- Offering closed on September 12, 2024; securities sold under effective shelf registration statement.

## SEC filing metadata
- accession: 0001493152-24-036055
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2024-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315224036055/0001493152-24-036055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224036055/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036055
- JSON: https://secwatch.observer/filing/0001493152-24-036055.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.